{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:33:16Z","timestamp":1793986396941,"version":"4.8.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Understanding the impact of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy on neonatal and maternal outcomes informs clinical decision-making. Here we report a national, population-based, matched cohort study to investigate associations between SARS-CoV-2 infection and, separately, COVID-19 vaccination just before or during pregnancy and the risk of adverse neonatal and maternal outcomes among women in Scotland with a singleton pregnancy ending at \u226520 weeks gestation. Neonatal outcomes are stillbirth, neonatal death, extended perinatal mortality, preterm birth (overall, spontaneous, and provider-initiated), small-for-gestational age, and low Apgar score. Maternal outcomes are admission to critical care or death, venous thromboembolism, hypertensive disorders of pregnancy, and pregnancy-related bleeding. We use conditional logistic regression to derive odds ratios adjusted for socio-demographic and clinical characteristics (aORs). We find that infection is associated with an increased risk of preterm (aOR=1.36, 95% Confidence Interval [CI]\u2009=\u20091.16\u20131.59) and very preterm birth (aOR = 1.90, 95% CI 1.20\u20133.02), maternal admission to critical care or death (aOR=1.72, 95% CI\u2009=\u20091.39\u20132.12), and venous thromboembolism (aOR = 2.53, 95% CI\u2009=\u20091.47\u20134.35). We find no evidence of increased risk for any of our outcomes following vaccination. These data suggest SARS-CoV-2 infection during pregnancy is associated with adverse neonatal and maternal outcomes, and COVID-19 vaccination remains a safe way for pregnant women to protect themselves and their babies against infection.<\/jats:p>","DOI":"10.1038\/s41467-023-40965-9","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T19:01:55Z","timestamp":1693335715000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Neonatal and maternal outcomes following SARS-CoV-2 infection and COVID-19 vaccination: a population-based matched cohort study"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0512-1640","authenticated-orcid":false,"given":"Laura","family":"Lindsay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3272-1040","authenticated-orcid":false,"given":"Clara","family":"Calvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4101-4535","authenticated-orcid":false,"given":"Ting","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Carruthers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4616-4732","authenticated-orcid":false,"given":"Cheryl","family":"Denny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Donaghy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7022-1322","authenticated-orcid":false,"given":"Lisa E. M.","family":"Hopcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7487-4363","authenticated-orcid":false,"given":"Leanne","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1288-3256","authenticated-orcid":false,"given":"Anna","family":"Goulding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9634-3299","authenticated-orcid":false,"given":"Emily","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4314-2685","authenticated-orcid":false,"given":"Bob","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5364-8757","authenticated-orcid":false,"given":"Krishnan","family":"Bhaskaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6593-9092","authenticated-orcid":false,"given":"Srinivasa Vittal","family":"Katikireddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9466-833X","authenticated-orcid":false,"given":"Colin","family":"McCowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5194-8083","authenticated-orcid":false,"given":"Colin R.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6848-5241","authenticated-orcid":false,"given":"Chris","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4453-623X","authenticated-orcid":false,"given":"Rachael","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4308-856X","authenticated-orcid":false,"given":"Sarah J.","family":"Stock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"key":"40965_CR1","first-page":"203","volume":"10","author":"ML Pathirathna","year":"2022","unstructured":"Pathirathna, M. L., Samarasekara, B. P. P., Dasanayake, T. S., Saravanakumar, P. & Weerasekara, I. Adverse perinatal outcomes in COVID-19 infected pregnant women: a systematic review and meta-analysis. Healthc. (Basel) 10, 203 (2022).","journal-title":"Healthc. (Basel)"},{"key":"40965_CR2","doi-asserted-by":"publisher","first-page":"m3320","DOI":"10.1136\/bmj.m3320","volume":"370","author":"J Allotey","year":"2020","unstructured":"Allotey, J. et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 370, m3320 (2020).","journal-title":"BMJ"},{"key":"40965_CR3","unstructured":"NHS England. Saving Babies\u2019 Lives Version Two (NHS England, 2019)."},{"key":"40965_CR4","unstructured":"Royal College of Midwives, Royal College of Obstetricians & Gyneacologists. Coronavirus (COVID-19) Infection in Pregnancy. Information for healthcare professionals (2022). https:\/\/www.rcog.org.uk\/media\/xsubnsma\/2022-03-07-coronavirus-covid-19-infection-in-pregnancy-v15.pdf."},{"key":"40965_CR5","unstructured":"National Institutes of Health. COVID-19 Treatments Guidelines - Special Considerations in Prengnacy (2022). https:\/\/www.covid19treatmentguidelines.nih.gov\/special-populations\/pregnancy\/]."},{"key":"40965_CR6","doi-asserted-by":"publisher","first-page":"e069741","DOI":"10.1136\/bmj-2021-069741","volume":"378","author":"ML Badell","year":"2022","unstructured":"Badell, M. L., Dude, C. M., Rasmussen, S. A. & Jamieson, D. J. Covid-19 vaccination in pregnancy. BMJ 378, e069741 (2022).","journal-title":"BMJ"},{"key":"40965_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33937-y","volume":"13","author":"C Calvert","year":"2022","unstructured":"Calvert, C. et al. A population-based matched cohort study of early pregnancy outcomes following COVID-19 vaccination and SARS-CoV-2 infection. Nat. Commun. 13, 6124 (2022).","journal-title":"Nat. Commun."},{"key":"40965_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35771-8","volume":"14","author":"C Calvert","year":"2023","unstructured":"Calvert, C. et al. A population-based matched cohort study of major congenital anomalies following COVID-19 vaccination and SARS-CoV-2 infection. Nat. Commun. 14, 107 (2023).","journal-title":"Nat. Commun."},{"key":"40965_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-022-04884-9","volume":"22","author":"AI Hagrass","year":"2022","unstructured":"Hagrass, A. I. et al. Maternal and neonatal safety outcomes after SAR-CoV-2 vaccination during pregnancy: a systematic review and meta-analysis. BMC Pregnancy Childbirth 22, 581 (2022).","journal-title":"BMC Pregnancy Childbirth"},{"key":"40965_CR10","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.ajic.2022.08.014","volume":"51","author":"I Hameed","year":"2022","unstructured":"Hameed, I. et al. Is it safe and effective to administer COVID-19 vaccines during pregnancy? A systematic review and meta-analysis. Am. J. Infect. Control 51, 582\u2013593 (2022).","journal-title":"Am. J. Infect. Control"},{"key":"40965_CR11","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","volume":"384","author":"TT Shimabukuro","year":"2021","unstructured":"Shimabukuro, T. T. et al. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N. Engl. J. Med. 384, 2273\u20132282 (2021).","journal-title":"N. Engl. J. Med."},{"key":"40965_CR12","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1001\/jamapediatrics.2022.3456","volume":"176","author":"A Watanabe","year":"2022","unstructured":"Watanabe, A. et al. Peripartum outcomes associated with COVID-19 vaccination during pregnancy: a systematic review and meta-analysis. JAMA Pediatr. 176, 1098\u20131106 (2022).","journal-title":"JAMA Pediatr."},{"key":"40965_CR13","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamapediatrics.2022.0001","volume":"176","author":"I Goldshtein","year":"2022","unstructured":"Goldshtein, I. et al. Association of BNT162b2 COVID-19 vaccination during pregnancy with neonatal and early infant outcomes. JAMA Pediatr. 176, 470\u2013477 (2022).","journal-title":"JAMA Pediatr."},{"key":"40965_CR14","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41591-021-01666-2","volume":"28","author":"SJ Stock","year":"2022","unstructured":"Stock, S. J. et al. SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland. Nat. Med 28, 504\u2013512 (2022).","journal-title":"Nat. Med"},{"key":"40965_CR15","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1093\/ije\/dyab243","volume":"51","author":"SJ Stock","year":"2022","unstructured":"Stock, S. J. et al. Cohort profile: the COVID-19 in Pregnancy in Scotland (COPS) dynamic cohort of pregnant women to assess effects of viral and vaccine exposures on pregnancy. Int J. Epidemiol. 51, e245\u2013e255 (2022).","journal-title":"Int J. Epidemiol."},{"key":"40965_CR16","doi-asserted-by":"publisher","first-page":"e042813","DOI":"10.1136\/bmjopen-2020-042813","volume":"10","author":"SJ Stock","year":"2020","unstructured":"Stock, S. J. et al. COVID-19 in Pregnancy in Scotland (COPS): protocol for an observational study using linked Scottish national data. BMJ Open 10, e042813 (2020).","journal-title":"BMJ Open"},{"key":"40965_CR17","doi-asserted-by":"publisher","first-page":"e069739","DOI":"10.1136\/bmj-2021-069739","volume":"377","author":"M Nana","year":"2022","unstructured":"Nana, M. et al. Diagnosis and management of covid-19 in pregnancy. Bmj 377, e069739 (2022).","journal-title":"Bmj"},{"key":"40965_CR18","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/infdis\/jiab626","volume":"225","author":"AK Regan","year":"2022","unstructured":"Regan, A. K., Arah, O. A., Fell, D. B. & Sullivan, S. G. SARS-CoV-2 infection during pregnancy and associated perinatal health outcomes: a National US Cohort Study. J. Infect. Dis. 225, 759\u2013767 (2022).","journal-title":"J. Infect. Dis."},{"key":"40965_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/bdr2.2081","volume":"115","author":"V Neelam","year":"2022","unstructured":"Neelam, V. et al. Pregnancy and infant outcomes by trimester of SARS-CoV-2 infection in pregnancy-SET-NET, 22 jurisdictions, January 25, 2020-December 31, 2020. Birth Defects Res. 115, 145\u2013159 (2022).","journal-title":"Birth Defects Res."},{"key":"40965_CR20","doi-asserted-by":"publisher","first-page":"e071416","DOI":"10.1136\/bmj-2022-071416","volume":"378","author":"DB Fell","year":"2022","unstructured":"Fell, D. B. et al. Risk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy: population based retrospective cohort study. BMJ 378, e071416 (2022).","journal-title":"BMJ"},{"key":"40965_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30052-w","volume":"13","author":"S Prasad","year":"2022","unstructured":"Prasad, S. et al. Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy. Nat. Commun. 13, 2414 (2022).","journal-title":"Nat. Commun."},{"key":"40965_CR22","unstructured":"Scottish Government. Coronavirus (COVID-19): Scotland\u2019s testing strategy\u2014adapting to the pandemic (2020). https:\/\/www.gov.scot\/publications\/coronavirus-covid-19-scotlands-testing-strategy-adapting-pandemic\/."},{"key":"40965_CR23","unstructured":"Scottish Government. Coronavirus (COVID-19)\u2014testing strategy: update\u2014March 2021 (2021). https:\/\/www.gov.scot\/publications\/scotlands-testing-strategy-update-march-2021\/."},{"key":"40965_CR24","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S2213-2600(22)00360-5","volume":"10","author":"SJ Stock","year":"2022","unstructured":"Stock, S. J. et al. Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study. Lancet Respir. Med. 10, 1129\u20131136 (2022).","journal-title":"Lancet Respir. Med."},{"key":"40965_CR25","unstructured":"Public-Health-Scotland\/COPS-public. https:\/\/github.com\/Public-Health-Scotland\/COPS-public (2022)."},{"key":"40965_CR26","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","volume":"12","author":"E von Elm","year":"2014","unstructured":"von Elm, E. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J. Surg. 12, 1495\u20131499 (2014).","journal-title":"Int J. Surg."},{"key":"40965_CR27","unstructured":"Public Health Scotland. Further changes to COVID-19 reporting (2022). https:\/\/publichealthscotland.scot\/news\/2022\/january\/further-changes-to-covid-19-reporting\/."},{"key":"40965_CR28","unstructured":"Scottish Government. Scottish Index of Multiple Deprivation 2020 (2020). https:\/\/www.gov.scot\/collections\/scottish-index-of-multiple-deprivation-2020\/."},{"key":"40965_CR29","unstructured":"Public Health Scotland. GPD Support: Deprivation (2023). https:\/\/www.isdscotland.org\/Products-and-Services\/GPD-Support\/Deprivation\/SIMD\/."},{"key":"40965_CR30","unstructured":"Scottish Government. Scottish Government Urban Rural Classification 2016 (2018). https:\/\/www.gov.scot\/publications\/scottish-government-urban-rural-classification-2016\/."},{"key":"40965_CR31","unstructured":"ISD Scotland. Data Dictionary A-Z: Ethnic Group (2023). https:\/\/www.ndc.scot.nhs.uk\/Dictionary-A-Z\/Definitions\/index.asp?Search=E&ID=243&Title=Ethnic%20Group."},{"key":"40965_CR32","unstructured":"Public Health Scotland. COVID-19\u2014Search criteria for highest risk patients for inclusion to the shielding list (2021). https:\/\/hpspubsrepo.blob.core.windows.net\/hps-website\/nss\/3008\/documents\/1_covid-19-search-criteria-highest-risk-patients.pdf."},{"key":"40965_CR33","unstructured":"Oxford University. QCovid\u00ae risk calculation 2023. https:\/\/www.qcovid.org."},{"key":"40965_CR34","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi, P., Concato, J., Kemper, E., Holford, T. R. & Feinstein, A. R. A simulation study of the number of events per variable in logistic regression analysis. J. Clin. Epidemiol. 49, 1373\u20131379 (1996).","journal-title":"J. Clin. Epidemiol."},{"key":"40965_CR35","doi-asserted-by":"crossref","unstructured":"Lindsay, L. & Calvert, C. Neonatal and maternal outcomes following SARS-CoV-2 infection and COVID-19 vaccination during pregnancy: a national population-based matched cohort study. https:\/\/github.com\/Public-Health-Scotland\/COPS-public (2022).","DOI":"10.2139\/ssrn.4322399"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40965-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40965-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40965-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T11:18:22Z","timestamp":1700219902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40965-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["40965"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-40965-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,29]]},"assertion":[{"value":"17 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.S. and C.R. were members of the Scottish Government\u2019s COVID-19 Advisory Group. A.S. is a member of the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) risk stratification subgroup and the Scottish Government\u2019s Committee on Pandemic Preparedness. C.R. is a member of the Scientific Pandemic Influenza Group on Modelling and the MHRA Covid 19 Vaccine Benefit and Risk Working Group. AS is a member of AstraZeneca\u2019s Thrombotic Thrombocytopenic Advisory Group. All roles are unremunerated. S.V.K. was co-chair of Scottish Government\u2019s Expert Reference Group on Ethnicity and COVID-19. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5275"}}